Astellas Pharma | 4503 - Net Income


Astellas Pharma reported JPY43.52B in Net Income for its fiscal quarter ending in March of 2026.





Net Income Change Date
Astellas Pharma JPY 43.52B 56.86B Mar/2026
Chugai Pharma JPY 115.42B 12.99B Mar/2026
Daiichi Sankyo JPY 86.63B 41.32B Dec/2025
Eisai JPY -3.25B 20.43B Mar/2026
Kyowa Hakko Kirin JPY 12.03B 22.41B Mar/2026
M3 JPY 7.45B 11.49B Mar/2026
Otsuka Holdings JPY 98.35B 32.86B Mar/2026
Shionogi JPY 46.93B 27.75B Mar/2026
Sumitomo Dainippon JPY -812M 88.47B Mar/2026
Takeda JPY -24.32B 127.96B Mar/2026
Terumo JPY 26.37B 6.28B Mar/2026